Seattle Genetics | Bienes



Assets Cambio Fecha
AbbVie USD 135.16B 8.26B 2024-12
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Astellas Pharma JPY 3.34T 112.09B 2025-03
Bayer EUR 109.18B 1.67B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Celldex Therapeutics USD 739.47M 52.87M 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
Eisai JPY 1.39T 46.32B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Exelixis USD 2.84B 110.44M 2025-04
Genmab DKK 6.59B 39.22B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 1.8B 222.5M 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sanofi 131.89B 906M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Takeda JPY 14.25T 858.5B 2025-03
Teva Pharmaceutical Industries USD 38.42B 911M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Xencor USD 904.69M 47.26M 2025-03



Seattle Genetics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.